出血性休克/复苏后给予萝卜硫素可减少小鼠脾巨噬细胞炎性细胞因子分泌并增强免疫效能
本研究在小鼠出血性休克/复苏(HS/R)模型中探究Nrf2通路激活剂萝卜硫素(SFN)对脾巨噬细胞免疫功能的调节作用。雄性C57/BL6野生型小鼠每组n=6,经压力控制性HS(MAP 35-45 mm Hg)90分钟后用回输血和0.9% NaCl复苏,复苏后立即及24、48小时腹腔注射SFN 50 mg/kg。结果显示SFN在给药后1小时内到达脾脏,增加脾Nrf2活化并降低HS/R后脾巨噬细胞细胞因子表达;HS/R组IL-6/IL-10比值6小时为51.79±9.99、24小时为15.70±3.35,HS/R+SFN组分别为20.54±5.35和8.60±2.37(P<0.05);SFN还增强LPS刺激下脾巨噬细胞的免疫效能。作者认为SFN可减少HS/R后脾巨噬细胞分泌的炎性细胞因子并增强其免疫效能,向更抗炎的表型转变。
要点
- 小鼠HS/R后腹腔注射SFN 50 mg/kg(复苏后立即及24、48小时)可在给药后1小时内到达脾脏。
- SFN增加HS/R后脾脏Nrf2活化并降低脾巨噬细胞细胞因子表达。
- HS/R组脾巨噬细胞IL-6/IL-10比值6小时51.79±9.99、24小时15.70±3.35,HS/R+SFN组6小时20.54±5.35、24小时8.60±2.37,P<0.05。
- SFN增强HS/R后脾巨噬细胞在LPS(100 ng/mL)刺激下分泌炎性细胞因子的免疫效能。
- 作者认为SFN可减少HS/R后脾巨噬细胞炎性细胞因子分泌并增强免疫效能,向更抗炎表型转变。
适用人群与场景
- 雄性C57/BL6野生型小鼠,每组n=6,接受压力控制性出血性休克(MAP 35-45 mm Hg)90分钟后液体复苏。
诊断标准与关键阈值
- 出血性休克模型:压力控制性HS,平均动脉压(MAP)35-45 mm Hg,持续90分钟。
- 复苏:回输抽出的血液和0.9% NaCl。
处置流程与药物剂量
- 萝卜硫素(SFN)50 mg/kg体重,腹腔注射,于复苏后立即给药,并在其后24小时和48小时各给药一次(依分组而定)。
- 复苏后6、24、72小时处死小鼠,取脾脏行Nrf2免疫荧光组织学检查,并分离脾巨噬细胞培养检测上清细胞因子分泌。
- 复苏后24小时分离的巨噬细胞用100 ng/mL细菌LPS处理以检测免疫效能。
- 采用基质辅助激光解吸/电离质谱成像验证腹腔注射后SFN在脾脏的分布。
研究设计与关键结果
- 研究类型:小鼠实验研究;雄性C57/BL6野生型小鼠,每组n=6;干预为HS/R后腹腔注射SFN 50 mg/kg(复苏后立即及24、48小时),对照为HS/R或假手术。
- SFN在给药后第一个小时内到达脾脏。
- SFN增加脾脏Nrf2活化并降低HS/R后脾巨噬细胞的细胞因子表达。
- 体外实验显示SFN使脾巨噬细胞呈现抗炎特性:IL-6/IL-10比值HS/R组6小时51.79±9.99、24小时15.70±3.35,HS/R+SFN组6小时20.54±5.35、24小时8.60±2.37,P<0.05。
- SFN改善HS/R后体外脾巨噬细胞免疫效能,表现为LPS刺激下炎性细胞因子分泌增加。
证据类型、等级与局限
- 证据类型:动物实验研究(小鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐;作者认为SFN可减少HS/R后脾巨噬细胞分泌的炎性细胞因子并增强其免疫效能,向更抗炎的表型转变。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objective : The purpose of this study was to investigate the immunomodulatory effects of sulforaphane (SFN), a nuclear factor erythroid 2-related factor (Nrf2) pathway activator, on splenic macrophages' immunocompetence after hemorrhagic shock/resuscitation (HS/R). Methods : Male C57/BL6 wild-type mice (n = 6 per group) were subjected to either pressure-controlled HS (MAP, 35-45 mm Hg) or a sham procedure surgery (without HS). After 90 minutes of HS, fluid resuscitation with withdrawn blood and 0.9% NaCl was performed. Sulforaphane (50 mg/kg of body weight) was applied intraperitoneally immediately after the resuscitation phase as well as 24 and 48 h thereafter, depending on group allocation. The mice were killed at 6, 24, and 72 h after resuscitation. After killing, spleens were harvested to perform Nrf2 immunofluorescence histology. Splenic macrophages were isolated and cultured to measure cytokine secretion in the cell culture supernatant. Furthermore, macrophages isolated after 24-hour resuscitation were treated with 100 ng/mL of bacterial LPS to measure immunocompetence. Matrix-assisted laser desorption/ionization mass spectrometry imaging was performed to verify the distribution of SFN in the spleen after intraperitoneal injection. Results : We showed that administered SFN reached the spleen within the first hour after administration. Furthermore, we identified that SFN increased splenic Nrf2 activation and decreased cytokine expression in splenic macrophages after HS/R. In addition, we showed that SFN exhibited splenic anti-inflammatory properties of macrophages in vitro (IL-6/IL-10-ratio of the HS/R group: 51.79 ± 9.99 [at 6 h] and 15.70 ± 3.35 [at 24 h] vs. HS/R + SFN group: 20.54 ± 5.35 [at 6 h] and 8.60 ± 2.37 [at 24 h], P < 0.05). Furthermore, SFN improved in vitro splenic macrophage immunocompetence after HS/R, as evidenced by the increased secretion of inflammatory cytokines in response to LPS stimulation in vitro . Conclusions : Our study shows that SFN can reduce inflammatory cytokines secreted by splenic macrophages after HS/R and increase their immunocompetence toward a more anti-inflammatory profile.
参考来源
- Qin K, Li Y, Liang W, et al. SULFORAPHANE ADMINISTRATION AFTER HEMORRHAGIC SHOCK/RESUSCITATION IN MICE REDUCES THE SECRETION OF INFLAMMATORY CYTOKINES AND INCREASES THE IMMUNOCOMPETENCE OF SPLENIC MACROPHAGES. Shock. 2022. PMID: 36533531. doi:10.1097/SHK.0000000000002074
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。